Dow, S&P 500, Nasdaq Futures Rise As Investors Shrug Off Fed Hold, Big Tech Earnings: IBRX, MSFT, SOFI, META In Focus
U.S. stock index futures rose overnight after the Fed held benchmark rates steady, though investors cited elevated inflation concerns. The Dow, S&P 500 and Nasdaq fell on Wednesday. Microsoft earnings beat and shares rose, while Meta and Qualcomm declined. Oil rose on U.S.-Iran retaliation. ImmunityBio jumped on UAE approval for Anktiva.
How this was made
The 30-second read
Why it matters
Traders can use the Fed decision framing for rates sensitivity, but the most tradable, company-specific catalysts here are the cited earnings/guidance outcomes for MSFT, META, SOFI and the UAE marketing approval for IBRX.
Market read
Overnight futures are slightly higher, but the prior session’s broad selloff and the specific earnings and approval catalysts create a stock-picking environment rather than a uniform risk-on move.
What to watch
The article highlights earnings reactions but does not detail guidance magnitude or segment drivers beyond broad descriptors, which could lead to overreaction in the immediate tape.
Background
The piece is a US market wrap: futures rise overnight after a Fed hold, while equities fell sharply in the prior regular session amid tech earnings and geopolitical tensions.
Ticker impact
ImmunityBio shares jumped over 8% after securing UAE marketing approval for Anktiva to treat certain bladder and lung cancers.
Bullish bias for the next session(s), with elevated volatility around follow-through and any additional rollout details.
The article cites a specific approval event tied to a named product and quantifies the immediate reaction, but provides no further commercial metrics.
Microsoft shares gained more than 7% overnight after reporting Q4 total revenue up 18% to $90B and EPS of $4.81 beat expectations.
Likely positive follow-through if guidance commentary and cloud demand remain consistent with the beat.
The text provides hard earnings numbers and a same-day stock reaction, which are directly actionable for positioning.
SoFi shares plunged more than 8% at the close after Q2 results showed flat profit guidance and declining tech revenue despite strong top-line results.
Bearish bias for the next session(s) as traders reprice forward expectations around guidance.
The article explicitly links the selloff to flat guidance and declining tech revenue, which are key drivers of valuation.
Meta shares were down about 7% overnight after weaker-than-expected Q2 profit and a soft sales outlook for the next quarter.
Downward pressure likely to persist near-term until investors get clearer visibility on ad demand and cost discipline.
The text ties the move to specific earnings underperformance and explicit outlook weakness.
Market effects
Mixed mega-cap earnings and a chip selloff (SMH, SOXX) suggest risk appetite is selective, with semis and ad-linked names under pressure.
Asian markets are mixed at the open, implying limited consensus direction as traders digest US rates and earnings.
Iran-US escalation lifts oil and geopolitical risk premia, which can feed into inflation expectations and discount rates globally.
Counterpoint
The Fed hold is framed as stoking inflation concerns, but futures are still edging higher, implying investors may be underestimating the market’s ability to look through near-term inflation noise.
Key entities
- macroFederal Reserve
Kept benchmark rates steady for a fifth consecutive session, with inflation concerns tied partly to energy pressures from the Iran conflict.
- equityMicrosoft
Reported Q4 revenue and EPS beats, sending the stock up more than 7% overnight.
- equityMeta Platforms
Reported weaker-than-expected Q2 profit and issued a soft sales outlook, sending the stock down about 7% overnight.
- equitySoFi Technologies
Q2 results included flat profit guidance and declining tech revenue, with shares down more than 8% at the close.
- equityImmunityBio
Secured UAE marketing approval for Anktiva for certain bladder and lung cancers, with shares up more than 8% overnight.
